Labs Have Two More Months To Report Private-Payer Data, CMS Says
Executive Summary
The US Medicare agency will allow laboratories two additional months – until May 30, 2017 – to report their private-payer pricing data, which will serve as the basis for clinical laboratory Medicare reimbursements starting in January. The agency said it is responding to industry feedback that more time is needed to collect the data.
You may also be interested in...
Lab Industry Says PAMA Reimbursement Rates Not Really Market-Based
The US Medicare agency was supposed to peg its Clinical Lab Fee Schedule reimbursement rates for 2018 to market-based prices supplied by labs under the 2014 Protecting Access to Medicare Act. The exercise might have increased payment rates for lab tests, but clinical labs say that the new Medicare rates actually make deep cuts that could disrupt access to laboratory services.
CMS Administrator Seema Verma: What Industry Can Expect
The Senate confirmed former health-policy consultant Seema Verma as administrator of the US Centers for Medicare and Medicaid Services earlier this month, and she was sworn in March 14. Medtech Insight took a look at some of Verma's policy positions affecting industry, including potential changes to accountable care organizations, appropriate-use criteria, the Centers for Medicare and Medicaid Innovation, lab payments, and telehealth services.
Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp
CMS issued a long-awaited final rule that will establish a new market-based approach to setting lab-test payment rates. The Medicare agency was convinced to delay implementation by one year, to 2018, and to make other tweaks to its policy that industry stakeholders say will make the system more accurate.